Faculty

Institution

Unit

Venue

J. Michael Mathis

Dean Graduate School of Biomedical Sciences ; Professor Pharmacology & Neuroscience

University of North Texas Health Science Center

Affiliations

Graduate School of Biomedical Sciences ; Pharmacology & Neuroscience

School of Biomedical Sciences

Pharmacology and Neuroscience

J. Michael Mathis is currently serving as a Graduate School Of Biomedical Sciences ; Pharmacology & Neuroscience Dean Graduate School of Biomedical Sciences ; Professor Pharmacology & Neuroscience at University of North Texas Health Science Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

J. Michael Mathis

University of North Texas Health Science Center

Dean Graduate School of Biomedical Sciences ; Professor Pharmacology & Neuroscience

You can click a keyword to filter the displayed items

oncology tumor biology cell biology cancer research cancer biology pharmacology medicine viral oncology cancer treatment oncogenes breast cancer genetics cancer cells gene therapy medicinal research molecular cancer gynecologic oncology cancer-associated virus cancer care cellular therapy tumor targeting virology gene expression breast oncology cancer genetics vascular biology medical virology endocrinology cancer genomics virus research gene vector molecular metabolism cell metabolism anti-cancer agents cytokines surgical oncology reproductive medicine liver physiology cancer management viral genetics oncolytic adenovirus pharmacotherapy malignant disease hepatotoxicity antiviral therapy cancer immunosurveillance aldosterone synthase endothelial dysfunction gene function cutaneous biology molecular neurobiology genome instability genetic incorporation adenovirus protein ix microsatellite instability biochemical genetics transcription regulation gene regulation molecular regulation endocrine research apoptosis tumor suppressors endocrine-related cancers wound care cancer prevention oncolytic adenoviruses functional display human metallothionein oncolytic adenovirus vector endometrial cancers estrogen biosynthesis placebo-controlled trial intracranial glioma cervical carcinogenesis aberrant methylation targeted delivery messenger rna granulosa cells genetic therapy polycyclic aromatic hydrocarbons enzymes glucocorticoids ovarian neoplasms mesenchymal stromal cells suicide thymidine kinase breast neoplasms carcinogenesis angiotensin ii cyclic hydrocarbons cell line

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 1232: Using Mesoporous Silica Nanoparticles (Msns) for Delivering the Mesoionic Compound Mih 2.4Bl in Treating Breast Cancer. Cancer Research (2021)

nanomaterialsdrug deliverytumor targetingnano-drug deliverymesoporous silica nanoparticleschemical engineeringnanoparticlesabstract 1232biomedical engineeringnanoparticle researchtherapeutic nanomaterialscontrolled releasebreast cancer

Abstract 300: An Improved Strategy for Delivering the Mesoionic Compound Mih 2.4Bl Utilizing Reconstituted High Density Nanoparticles (Rhdl) in Treating Breast Cancer. Cancer Research (2021)

abstract 300radiation oncologydrug deliverytumor targetingnano-drug deliverynanoparticlesnanomedicinehigh density nanoparticlesbiomedical engineeringnanoparticle researchtherapeutic nanomaterialscontrolled releasebreast cancer

Cxcl12 Retargeting of an Oncolytic Adenovirus Vector to the Chemokine Cxcr4 and Cxcr7 Receptors in Breast Cancer. Journal of Cancer Therapy (2021)

breast oncologyoncogenesradiation oncologytumor biologycancer biologycancer-associated virusimmunologycell biologyviral oncologycancer researchoncolytic adenovirus vectorcxcl12 retargetingcancer cellsreceptorstumor microenvironmentbreast cancer

Cytotoxic Activity of the Mesoionic Compound Mih 2.4Bl in Breast Cancer Cell Lines. Breast Cancer Basic and Clinical Research (2020)

Luciana Amaral de Mascena CostaAshlyn C HarmonAlvaro Aguiar Coelho TeixeiraFilipe Cássio Silva de LimaSilvany de Sousa AraújoFabio Del PieroHelivaldo Diógenes da Silva SouzaPetrônio Filgueiras de Athayde FilhoSeverino Alves JuniorMaria de Mascena Diniz MaiaAurea WischralManoel Adrião Gomes FilhoJ Michael Mathis

breast oncologycancer biologymesoionic compoundcytotoxic activitycancer researchmedicinepharmacologyoncologybreast cancer

Synthesis and Investigation of Phthalocyanine-Biotin Conjugates. WORLD SCIENTIFIC eBooks (2020)

Elizabeth A. OkothZehua ZhouBenson OngaroraAlyssa StutesJ. Michael MathisM. Graça H. Vicente

phthalocyanine-biotin conjugatesbiochemistrychemical synthesismaterials sciencemolecular biologyorganic chemistryorganic synthesis

Abstract 4776: Characterizing an Oncolytic Adenovirus Modified With the Cxcl12 Ligand for Breast Cancer Therapy. Cancer Research (2019)

breast oncologyoncogenesoncolytic adenoviruspathologyradiation oncologytumor biologycxcl12 ligandcancer-associated virusbreast cancer therapyimmunologyviral oncologymedical virologycancer cellscancer treatmentoncologybreast cancer

Ccdc 1873629: Experimental Crystal Structure Determination. The Cambridge Structural Database (2019)

crystal structurescrystal researchccdc 1873629structural chemistrycrystal engineeringcrystallographystructure determinationstructure elucidationchemistrychemical structure

Surface Modification Strategy Based on the Conjugation of Nayf4: 5%EU Luminescent Nanoprobe With Organic Aromatic Compounds for Application in Bioimaging Assays. Journal of Nanoparticle Research (2019)

Rodrigo da Silva VianaLuciana Amaral de Mascena CostaAndressa N. R. LealTyrslai M. WilliamsLiquian LuanGuanyu ZhangMaodie WangAshlyn C. HarmonJanaina V. dos AnjosRafael CuetoManoel Adrião Gomes FilhoEduardo H. L. FalcãoMaria G. H. VicenteSeverino A. JuniorJ. Michael Mathis

nanomaterialsbioimaging assayssurface modification strategynanoparticlessurface modificationnanotechnologyorganic aromatic compoundsnanoparticle researchmaterials science

Synthesis, Characterization, and Evaluation of Near-Ir Boron Dipyrromethene Bioconjugates for Labeling of Adenocarcinomas by Selectively Targeting the Epidermal Growth Factor Receptor. Journal of Medicinal Chemistry (2019)

Nichole E. M. KaufmanQianli MengKaitlin E. GriffinSitanshu S. SinghAchyut DahalZehua ZhouFrank R. FronczekJ. Michael MathisSeetharama D. JoisM. Graça H. Vicente

drug deliverytumor biologydrug analysisphotomedicinebioconjugationdrug targetingpharmaceutical chemistrytumor targetingcell biologymedicinal researchanalytical chemistrymedicinal chemistrymolecular cancermedicinepharmacologycatalyst preparationdrug discoverynanoparticle research

Tumor-Targeting Nirf Nanogumbos With Cyclodextrin-Enhanced Chemo/Photothermal Antitumor Activities. ACS Applied Materials & Interfaces (2019)

Mi ChenRocío L. PérezPu DuNimisha BhattaraiKaren C. McDonoughSudhir RavulaRevati KumarJ. Michael MathisIsiah M. Warner

nanomaterialstumor targetinganti-cancer agentschemical engineeringadvanced materialsnanomedicinetherapeutic nanomaterialsnanotechnologymaterial researchtumor-targeting nirf nanogumbospharmaceutical nanotechnologycancer treatmentapplied physicscancer careoncologymaterials science

1
2
3
4
5
16
10 / page

J. Michael Mathis

Dean Graduate School of Biomedical Sciences ; Professor Pharmacology & Neuroscience

University of North Texas Health Science Center

Affiliations

Graduate School of Biomedical Sciences ; Pharmacology & Neuroscience

School of Biomedical Sciences

Pharmacology and Neuroscience

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

J. Michael Mathis

University of North Texas Health Science Center

Dean Graduate School of Biomedical Sciences ; Professor Pharmacology & Neuroscience

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 1232: Using Mesoporous Silica Nanoparticles (Msns) for Delivering the Mesoionic Compound Mih 2.4Bl in Treating Breast Cancer. Cancer Research (2021)

Abstract 300: An Improved Strategy for Delivering the Mesoionic Compound Mih 2.4Bl Utilizing Reconstituted High Density Nanoparticles (Rhdl) in Treating Breast Cancer. Cancer Research (2021)

Cxcl12 Retargeting of an Oncolytic Adenovirus Vector to the Chemokine Cxcr4 and Cxcr7 Receptors in Breast Cancer. Journal of Cancer Therapy (2021)

Cytotoxic Activity of the Mesoionic Compound Mih 2.4Bl in Breast Cancer Cell Lines. Breast Cancer Basic and Clinical Research (2020)

breast oncologycancer biologymesoionic compoundcytotoxic activitycancer researchmedicinepharmacologyoncologybreast cancer

Synthesis and Investigation of Phthalocyanine-Biotin Conjugates. WORLD SCIENTIFIC eBooks (2020)

Elizabeth A. OkothZehua ZhouBenson OngaroraAlyssa StutesJ. Michael MathisM. Graça H. Vicente

phthalocyanine-biotin conjugatesbiochemistrychemical synthesismaterials sciencemolecular biologyorganic chemistryorganic synthesis

Abstract 4776: Characterizing an Oncolytic Adenovirus Modified With the Cxcl12 Ligand for Breast Cancer Therapy. Cancer Research (2019)

Ccdc 1873629: Experimental Crystal Structure Determination. The Cambridge Structural Database (2019)

crystal structurescrystal researchccdc 1873629structural chemistrycrystal engineeringcrystallographystructure determinationstructure elucidationchemistrychemical structure

nanomaterialsbioimaging assayssurface modification strategynanoparticlessurface modificationnanotechnologyorganic aromatic compoundsnanoparticle researchmaterials science

Nichole E. M. KaufmanQianli MengKaitlin E. GriffinSitanshu S. SinghAchyut DahalZehua ZhouFrank R. FronczekJ. Michael MathisSeetharama D. JoisM. Graça H. Vicente

Tumor-Targeting Nirf Nanogumbos With Cyclodextrin-Enhanced Chemo/Photothermal Antitumor Activities. ACS Applied Materials & Interfaces (2019)

Mi ChenRocío L. PérezPu DuNimisha BhattaraiKaren C. McDonoughSudhir RavulaRevati KumarJ. Michael MathisIsiah M. Warner

1
2
3
4
5
16
10 / page